GlassScriptPhysician profile
Shivani Patel
NPI 1235405820
$2,686.08
in general payments reported to CMS, 2019-2025
21 companies · $854 in 2025
The $854 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $38.82 · 2023: $945 · 2024: $848 · 2025: $854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,439 · Education: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,438.62 |
| Education | $208.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $557.15 | 2023-2025 | |
| Abbvie INC. | $437.88 | 2023-2025 | |
| Janssen Biotech, INC. | $356.04 | 2022-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $178.61 | 2023-2024 | Dupixent, Libtayo |
| Arcutis Biotherapeutics, INC. | $147.55 | 2023-2025 | Zoryve |
| Genzyme Corporation | $132.74 | 2023-2025 | |
| Ucb, INC. | $132.43 | 2023-2024 | Bimzelx, Cimzia |
| Lilly USA, LLC | $125.77 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Paragon 28, INC. | $112.31 | 2024 | Mtp |
| Sun Pharmaceutical Industries INC. | $90.23 | 2023-2025 | Ilumya |
| E.R. Squibb & Sons, L.L.C. | $82.40 | 2024 | Sotyktu |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.03 | 2024 | Spevigo |
| Dermavant Sciences, INC. | $58.64 | 2023 | Vtama |
| Pfizer INC. | $47.70 | 2024-2025 | |
| Amgen INC. | $43.44 | 2022-2025 | Otezla |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $34.44 | 2023 | Adbry |
| Strata Skin Sciences, INC. | $32.06 | 2025 | Xtrac |
| Fresenius Kabi USA, LLC | $17.61 | 2023 | Idacio |
| Journey Medical Corporation | $14.47 | 2025 | |
| Genentech USA, INC. | $12.79 | 2023 | Erivedge |
| Incyte Corporation | $11.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shivani Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.